We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

097955:KRXCJ Cheiljedang Corporation Analysis

Data as of 2026-05-31 - not real-time

₩126,000.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is currently trading near the lower bound of its 52‑week range, reflecting a bearish market sentiment. Technical indicators show an oversold condition, with the RSI well below the neutral zone. The MACD line sits below its signal, generating a bearish histogram. Volume has been rising, indicating heightened participation as price tests support. Despite the defensive nature of the packaged‑foods sector, the company's profit margins remain thin and earnings are negative. Cash generation is positive, but the dividend payout exceeds earnings, raising concerns about sustainability.
The discounted cash‑flow model values the firm at roughly half of the current market price, suggesting overvaluation. A low beta points to limited systematic risk, yet the recent price swing has been volatile. Debt levels are high relative to equity, adding balance‑sheet pressure. The dividend yield is attractive but likely unsustainable given the payout ratio. Overall, the stock faces downside pressure in the near term while offering limited upside without a clear catalyst. Investors should weigh the defensive sector exposure against the weak fundamentals and valuation gap.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • bearish MACD divergence
  • price testing support level
  • rising volume suggests possible reversal

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • valuation well above DCF estimate
  • negative earnings and thin margins
  • high debt burden

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • diversified business segments including biotech and logistics
  • stable cash flow generation
  • defensive sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth6.00%
Profit Margin-1.81%
ROE-0.96%
ROA2.41%
Debt/Equity103.50
Op. Cash Flow₩2674.4B
Free Cash Flow₩660.9B

Technical Analysis

TrendBearish
RSI33.4
Support₩125,000.00
Resistance₩143,000.00
MA 20₩133,010.00
MA 50₩133,526.00
MA 200₩137,275.00
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07

Valuation

Fair Value₩68,984.40
GradeOvervalued
TypeValue
Dividend Yield4.80%

Risk Assessment

Beta0.25
Volatility21.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.